NFKB1 and ovarian carcinoma: In our study, we found that propofol upregulated miR-9 expression in ovarian cancer ES-2cells, by which it inhibited NF-κB activation and its downstream MMP-9 expression,leading to the inhibition of cell growth and invasion of ES-2 cells.